Search result for 'oncology products'

Zydus Lifesciences and Synthon BV have partnered to develop and commercialize a novel 505(B)(2) oncology product for the US market, aiming to provide patients with alternative treatment options for...

Aurobindo Pharma Ltd will acquire the remaining 49% stake in GLS Pharma Ltd for Rs 22.5 crore, making it a wholly-owned subsidiary. The deal is expected to be completed by December 31, 2024.